Leng Lin, Bai Huiran, Li Honglei, Liu Dongle, Han Yanfeng, Wu Xiaoming
Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Eye Institute of Shandong First Medical University, Qingdao, China.
Front Med (Lausanne). 2022 Mar 10;9:815966. doi: 10.3389/fmed.2022.815966. eCollection 2022.
To compare the impact of anterior capsule polishing (ACP) during cataract surgery on the rate of neodymium: YAG (Nd: YAG) laser capsulotomy in pseudophakic eyes with two multifocal intraocular lenses (MIOLs).
Data were collected on patients who underwent cataract surgery and implanted segmental refractive MIOLs (SBL-3, Lenstec) or diffracted MIOLs (AT LISA tri 839MP, Carl Zeiss Meditec). The participants were divided into ACP and non-ACP groups based on whether the anterior capsule was polished. The primary outcome measure was whether Nd: YAG capsulotomy was performed during the 3 years follow-up. We used Kaplan-Meier survival curves to determine the time from IOL implantation to Nd: YAG laser capsulotomy.
ACP and non-ACP groups comprised 70 and 60 eyes, respectively. One year postoperatively, 7.14% of ACP group eyes and 8.33% of non-ACP group required Nd: YAG laser capsulotomy ( > 0.99). After 2 years, it was 24.29 and 18.33%, respectively ( = 0.52), while after 3 years, it reached 30.0 and 28.33% ( = 0.85). No distinct difference existed in the probability of using Nd: YAG laser in both groups evaluated using Kaplan-Meier survival curves ( = 0.81). Patients with diffractive MIOLs (AT LISA tri 839MP) implantation were more likely to require Nd: YAG laser capsulotomy ( < 0.01).
Polishing the anterior capsule had no remarkable effect on reducing the rate of Nd: YAG laser capsulotomy following phacoemulsification in MIOLs. Patients with diffractive MIOLs implantation had a high probability of requiring Nd: YAG laser capsulotomy.
比较白内障手术期间前囊抛光（ACP）对两种多焦点人工晶状体（MIOL）植入的假晶状体眼中钕：钇铝石榴石（Nd：YAG）激光晶状体囊切开术发生率的影响。
收集接受白内障手术并植入分段屈光性MIOL（SBL-3，Lenstec）或衍射性MIOL（AT LISA tri 839MP，卡尔蔡司医疗技术公司）的患者数据。根据前囊是否抛光，将参与者分为ACP组和非ACP组。主要观察指标是在3年随访期间是否进行了Nd：YAG晶状体囊切开术。我们使用Kaplan-Meier生存曲线来确定从人工晶状体植入到Nd：YAG激光晶状体囊切开术的时间。
ACP组和非ACP组分别有70只眼和60只眼。术后1年，ACP组7.14%的眼和非ACP组8.33%的眼需要进行Nd：YAG激光晶状体囊切开术（P>0.99）。2年后，分别为24.29%和18.33%（P = 0.52），而3年后达到30.0%和28.33%（P = 0.85）。使用Kaplan-Meier生存曲线评估，两组使用Nd：YAG激光的概率没有明显差异（P = 0.81）。植入衍射性MIOL（AT LISA tri 839MP）的患者更有可能需要进行Nd：YAG激光晶状体囊切开术（P<0.01）。
前囊抛光对降低MIOL白内障超声乳化术后Nd：YAG激光晶状体囊切开术的发生率没有显著影响。植入衍射性MIOL的患者很有可能需要进行Nd：YAG激光晶状体囊切开术。
